Compare ETFs: THNR
THNR
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| THNR | 3.80% | 17.49% | - | - | 3.37% |
Top 25 Holdings
| THNR - Amplify Weight Loss Drug & Treatment ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | NVO | Novo Nordisk A/S | 13.32% |
| 2 | LLY | Eli Lilly and Company | 12.91% |
| 3 | n/a | OTHER ASSETS AND LIABILITIES | 12.01% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.84% |
| 5 | AMGN | Amgen Inc. | 6.79% |
| 6 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 6.26% |
| 7 | MRK | Merck & Co., Inc. | 5.19% |
| 8 | SWX: ROG | Roche Holding AG | 5.01% |
| 9 | AZN | AstraZeneca PLC | 4.98% |
| 10 | HKG: 1801 | Innovent Biologics, Inc. | 4.93% |
| 11 | TYO: 4507 | Shionogi & Co., Ltd. | 4.93% |
| 12 | ABBV | AbbVie Inc. | 4.92% |
| 13 | PFE | Pfizer Inc. | 4.64% |
| 14 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 4.04% |
| 15 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.78% |
| 16 | HIMS | Hims & Hers Health, Inc. | 3.31% |
| 17 | CPH: ZEAL | Zealand Pharma A/S | 1.92% |
| 18 | VKTX | Viking Therapeutics, Inc. | 1.62% |
| 19 | SRRK | Scholar Rock Holding Corporation | 1.60% |
| 20 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H | 1.01% |
| 21 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 0.89% |
| 22 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 0.59% |
| 23 | n/a | US DOLLARS | -11.49% |
| 24 | n/a | n/a | n/a |
| 25 | n/a | n/a | n/a |
| View THNR holdings | |||